Skip to main content
Nureca Limited logo

Nureca Limited — Investor Relations & Filings

Ticker · NURECA ISIN · INE0DSF01015 LEI · 894500NRGNYR07CDBN26 BSE.NS Wholesale and retail trade
Open in API
Filings indexed 302 across all filing types
Latest filing 2024-05-08 Regulatory Filings
Country IN India
Listing BSE.NS NURECA

About Nureca Limited

https://www.nureca.com

Nureca Limited specializes in the development and distribution of home healthcare devices and lifestyle products. The company operates through several key brands, most notably Dr Trust, Dr Physio, and Trumom. Its product portfolio includes medical diagnostic tools such as blood pressure monitors, pulse oximeters, nebulizers, and thermometers, as well as wellness equipment like massagers and personal scales. Nureca utilizes a digital-first business model, prioritizing e-commerce channels to provide consumers with accessible medical technology. The company focuses on integrating clinical-grade accuracy with user-centric design to support chronic disease management, fitness tracking, and maternal care. By offering a diverse range of health monitoring solutions, Nureca aims to empower individuals to manage their well-being through proactive and data-driven home-based care.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results/Other business matters
Regulatory Filings Classification · 95% confidence The document is a notice from Nureca Limited informing the stock exchanges about an upcoming Board Meeting scheduled for May 15, 2024. The purpose of the meeting is to consider and approve the audited financial results for the quarter and full year ended March 31, 2024. The document is short (1430 characters) and serves as an announcement of a future event rather than containing any financial data or results itself. It does not contain the financial results or detailed report but only informs about the meeting where such results will be approved. Therefore, it is not an Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). It is also not a Board/Management Information (MANG) document since it does not announce changes in board or management. The document fits best as a Regulatory Filing (RNS) because it is a regulatory announcement about a board meeting related to financial results approval, without the actual report or results included.
2024-05-08 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Nureca Limited's Dr Trust brand has been recognized as a 'Well Known Trademark' by the Indian Trademark Registry. It contains no financial data, no regulatory filings, no voting results, no management changes, no earnings information, or any other report-type content. The document is short (4304 characters) and serves as a public relations announcement rather than a formal financial or regulatory filing. It does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. Given the nature of the content, the best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2024-04-02 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice from Nureca Limited informing stock exchanges about the closure of the trading window in compliance with insider trading regulations. It mentions the trading window closure period related to the upcoming declaration of audited financial results for the fiscal year ending March 31, 2024. The document does not contain any financial data, detailed report, or analysis. It is an announcement related to trading restrictions rather than a financial report or detailed filing. The document length is only 1560 characters, indicating it is a brief announcement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-03-27 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Nureca's flagship brand, Dr Trust, has been ranked No.1 in India's Top Home Healthcare & Wellness Brands. It contains no financial data, no regulatory filing references, no voting results, no management changes, no earnings or financial report content. The document is short (2974 characters) and serves as a public relations announcement rather than a formal financial or regulatory filing. It does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. The best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2024-03-01 English
Copy of Newspaper Publication
Interim / Quarterly Report Classification · 95% confidence The document contains multiple excerpts of unaudited financial results for the quarter and nine months ended December 31, 2023, for different companies. It includes detailed financial data such as total income, net profit/loss, earnings per share, and notes about the approval of these results by the Audit Committee and Board of Directors. The document references Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to quarterly financial results. The presence of detailed financial figures and the period covered (quarter and nine months ended December 31, 2023) indicates this is a comprehensive interim/quarterly financial report rather than a brief announcement or a certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2024-02-08 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is titled 'Investor Presentation (Q3’FY24)' and is addressed to stock exchanges referencing the un-audited standalone and consolidated financial results for the third quarter and nine months ended December 31, 2023. It contains detailed financial performance highlights, strategic pillars, product information, and growth metrics. The content is consistent with a presentation aimed at investors, focusing on financials, strategy, and market position rather than a formal earnings release or full financial report. The length is substantial (15,000 characters), indicating a full presentation rather than a brief announcement. Therefore, the document fits the category of an Investor Presentation (IP).
2024-02-07 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.